Table of Contents

    Topic review

    MT-ND6 Gene

    Subjects: Genetics
    View times: 4
    Submitted by: Lily Guo
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6

    1.  Introduction

    The MT-ND6 gene provides instructions for making a protein called NADH dehydrogenase 6. This protein is part of a large enzyme complex known as complex I, which is active in mitochondria. Mitochondria are structures within cells that convert the energy from food into a form that cells can use. These cellular structures produce energy through a process called oxidative phosphorylation, which uses oxygen and simple sugars to create adenosine triphosphate (ATP), the cell's main energy source.

    Complex I is one of several enzyme complexes necessary for oxidative phosphorylation. Within mitochondria, these complexes are embedded in a tightly folded, specialized membrane called the inner mitochondrial membrane. During oxidative phosphorylation, mitochondrial enzyme complexes carry out chemical reactions that drive the production of ATP. Specifically, they create an unequal electrical charge on either side of the inner mitochondrial membrane through a step-by-step transfer of negatively charged particles called electrons. This difference in electrical charge provides the energy for ATP production.

    Complex I is responsible for the first step in the electron transport process, the transfer of electrons from a molecule called NADH to another molecule called ubiquinone. Electrons are then passed from ubiquinone through several other enzyme complexes to provide energy for the generation of ATP.

    2. Health Conditions Related to Genetic Changes

    2.1. Leber hereditary optic neuropathy

    Several mutations in the MT-ND6 gene have been identified in people with Leber hereditary optic neuropathy. Each of these mutations changes a single protein building block (amino acid) in the NADH dehydrogenase 6 protein. One common MT-ND6 mutation is responsible for about 14 percent of all cases of Leber hereditary optic neuropathy, and it is the most common cause of this disorder among people of French Canadian descent. This genetic change, written as T14484C or Met64Val, replaces the amino acid methionine with the amino acid valine at protein position 64. The T14484C mutation is associated with a good long-term prognosis; affected people with this genetic change have a 37 percent to 65 percent chance of some visual recovery.

    Researchers are investigating how mutations in the MT-ND6 gene lead to Leber hereditary optic neuropathy. These genetic changes appear to prevent complex I from interacting normally with ubiquinone, which may affect the generation of ATP. MT-ND4 mutations may also increase the production within mitochondria of potentially harmful molecules called reactive oxygen species. It remains unclear, however, why the effects of these mutations are often limited to the nerve that relays visual information from the eye to the brain (the optic nerve). Additional genetic and environmental factors probably contribute to the vision loss and other medical problems associated with Leber hereditary optic neuropathy.

    2.2. Other disorders

    A mutation in the MT-ND6 gene also has been identified in a small number of people with Leigh syndrome, a progressive brain disorder that typically appears in infancy or early childhood. Affected children may experience vomiting, seizures, delayed development, muscle weakness, and problems with movement. Heart disease, kidney problems, and difficulty breathing can also occur in people with this disorder.

    The MT-ND6 mutation that can cause Leigh syndrome, written as G14459A or Ala72Val, replaces the amino acid alanine with the amino acid valine at protein position 72. This genetic change also has been found in people with Leber hereditary optic neuropathy and a movement disorder called dystonia, which involves involuntary muscle contractions, tremors, and other uncontrolled movements. This mutation appears to disrupt the normal assembly or activity of complex I in mitochondria. It is not known, however, how this MT-ND6 gene alteration is related to the specific features of Leigh syndrome, Leber hereditary optic neuropathy, or dystonia. It also remains unclear why a single mutation can cause such varied signs and symptoms in different people.

    3. Other Names for This Gene

    • mitochondrially encoded NADH dehydrogenase 6
    • MTND6
    • NADH dehydrogenase 6
    • NADH dehydrogenase subunit 6
    • NADH-ubiquinone oxidoreductase chain 6
    • NADH-ubiquinone oxidoreductase, subunit ND6
    • ND6
    • NU6M_HUMAN

    The entry is from https://medlineplus.gov/genetics/gene/mt-nd6

    References

    1. Baracca A, Solaini G, Sgarbi G, Lenaz G, Baruzzi A, Schapira AH, Martinuzzi A,Carelli V. Severe impairment of complex I-driven adenosine triphosphate synthesisin leber hereditary optic neuropathy cybrids. Arch Neurol. 2005 May;62(5):730-6.
    2. Carelli V, Ghelli A, Bucchi L, Montagna P, De Negri A, Leuzzi V, Carducci C,Lenaz G, Lugaresi E, Degli Esposti M. Biochemical features of mtDNA 14484(ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy.Ann Neurol. 1999 Mar;45(3):320-8.
    3. Chinnery PF, Andrews RM, Turnbull DM, Howell NN. Leber hereditary opticneuropathy: Does heteroplasmy influence the inheritance and expression of theG11778A mitochondrial DNA mutation? Am J Med Genet. 2001 Jan 22;98(3):235-43.
    4. Fauser S, Leo-Kottler B, Besch D, Luberichs J. Confirmation of the 14568mutation in the mitochondrial ND6 gene as causative in Leber's hereditary opticneuropathy. Ophthalmic Genet. 2002 Sep;23(3):191-7.
    5. Gropman A, Chen TJ, Perng CL, Krasnewich D, Chernoff E, Tifft C, Wong LJ.Variable clinical manifestation of homoplasmic G14459A mitochondrial DNAmutation. Am J Med Genet A. 2004 Feb 1;124A(4):377-82.
    6. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics. 2001 Jul;3(3):119-25. Review.
    7. Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh diseasecaused by the mitochondrial DNA G14459A mutation in unrelated families. AnnNeurol. 2000 Jul;48(1):102-4.
    8. Lenaz G, Baracca A, Carelli V, D'Aurelio M, Sgarbi G, Solaini G. Bioenergeticsof mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta. 2004 Jul 23;1658(1-2):89-94. Review.
    9. Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation inmitochondrial complex I genes: mutation or polymorphism? J Med Genet. 2006Feb;43(2):175-9.
    10. Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, Robinson BH.Clinical variability in maternally inherited leber hereditary optic neuropathywith the G14459A mutation. Am J Med Genet A. 2004 Feb 1;124A(4):372-6.
    11. Valentino ML, Avoni P, Barboni P, Pallotti F, Rengo C, Torroni A, Bellan M,Baruzzi A, Carelli V. Mitochondrial DNA nucleotide changes C14482G and C14482A inthe ND6 gene are pathogenic for Leber's hereditary optic neuropathy. Ann Neurol. 2002 Jun;51(6):774-8.
    More

    Keywords